Off the Scales — the impact of weight-loss jabs, from our bodies to the pharma sector
Focusing on Novo Nordisk, Aimee Donnellan’s book ranges across R&D, patents, medical effects and the stigma attached to obesityLife & Arts
Consulta l'articolo completo a questo indirizzo
https://www.ft.com/content/b66e49ee-dfbf-4a8b-8af7-6839dee6f276?segmentId=776b81d7-dd92-c731-e669-99cdd37d3a96#myft:my-news:rss



